- Home
- OGEN
OGEN
Oragenics Inc.
as 07-26-2024 4:00pm EST
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | SARASOTA |
| Market Cap: | 9.8M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 135.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -8.54 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.97 - $7.74 | Next Earning Date: | 08-12-2024 |
| Revenue: | $20,629 | Revenue Growth: | -84.54% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Oragenics Inc. (OGEN)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Telling Fred | OGEN | Director | Nov 30 '23 | Sell | $3.57 | 3,500 | $12,488.35 | 38,345 | SEC Form 4 |
Latest Oragenics Inc. News
OGEN Breaking Stock News: Dive into OGEN Ticker-Specific Updates for Smart Investing
GlobeNewswire
17 days ago
Oragenics Improves Intranasal Drug Formulation for Treating Concussed Patients
GlobeNewswire
a month ago
Oragenics Develops Automated Intranasal Device for Treating Concussed Patients
GlobeNewswire
a month ago
Oragenics, Inc. Announces Closing of Public Offering
MT Newswires
a month ago
Top Midday Decliners
GlobeNewswire
a month ago
Oragenics, Inc. Announces Pricing of Public Offering
GlobeNewswire
a month ago
Oragenics, Inc. Announces Proposed Public Offering
GlobeNewswire
a month ago
Oragenics, Inc. Announces NYSE American Acceptance of Plan of Compliance
Journal-News, Hamilton, Ohio
2 months ago
Retiring ODW executive to be first inductee in Hamilton Business Hall of Fame
Compare OGEN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OGEN Oragenics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.